tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab price target raised to DKK 2,500 from DKK 2,250 at Deutsche Bank
The FlyGenmab price target raised to DKK 2,500 from DKK 2,250 at Deutsche Bank
4d ago
GMAB
3 Best Stocks With 140%+ Upside to Buy in September, According to Analysts
PremiumMarket News
3 Best Stocks With 140%+ Upside to Buy in September, According to Analysts
4d ago
GMAB
OCUL
Genmab’s Petosemtamab Trial Emerges as a New Catalyst in Colorectal Cancer
PremiumCompany Announcements
Genmab’s Petosemtamab Trial Emerges as a New Catalyst in Colorectal Cancer
10d ago
GMAB
Genmab Updates Articles of Association, Expands Capital-Raising Flexibility
PremiumCompany Announcements
Genmab Updates Articles of Association, Expands Capital-Raising Flexibility
24d ago
6K
GMAB
Genmab: Buy Rating Backed by Pivotal Epkinly Data Conviction and Blockbuster Potential Across Key Oncology Programs
PremiumRatings
Genmab: Buy Rating Backed by Pivotal Epkinly Data Conviction and Blockbuster Potential Across Key Oncology Programs
24d ago
GMAB
Genmab Boosts Share Capital After Employee Warrant Exercise
PremiumCompany AnnouncementsGenmab Boosts Share Capital After Employee Warrant Exercise
24d ago
6K
GMAB
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
Premium
Market News
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
25d ago
GMAB
RPRX
Genmab price target raised to $35 from $33 at Morgan Stanley
Premium
The Fly
Genmab price target raised to $35 from $33 at Morgan Stanley
29d ago
GMAB
Genmab price target raised to $42 from $40 at Guggenheim
PremiumThe Fly
Genmab price target raised to $42 from $40 at Guggenheim
29d ago
GMAB
Genmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential
PremiumRatings
Genmab: Buy Rating Backed by Epkinly Outperformance and $8 Billion Peak-Sales Pipeline Potential
29d ago
GMAB
Genmab’s Earnings Call Highlights Growth, Upgraded Outlook
PremiumCompany Announcements
Genmab’s Earnings Call Highlights Growth, Upgraded Outlook
29d ago
GMAB
Genmab Lifts 2026 Outlook on Strong H1 Results and Positive Epcoritamab Data
PremiumCompany Announcements
Genmab Lifts 2026 Outlook on Strong H1 Results and Positive Epcoritamab Data
30d ago
6K
GMAB
Genmab reports Q2 revenue $1.155B vs. $925M last year
PremiumThe FlyGenmab reports Q2 revenue $1.155B vs. $925M last year
30d ago
GMAB
Genmab raises FY26 revenue view to $4.325B-$4.525B from $4.065B-$4.395B
Premium
The Fly
Genmab raises FY26 revenue view to $4.325B-$4.525B from $4.065B-$4.395B
30d ago
GMAB
Genmab Opens New Front in Solid Tumor Battle With GEN1119 Phase 1 Trial
Premium
Company Announcements
Genmab Opens New Front in Solid Tumor Battle With GEN1119 Phase 1 Trial
1M ago
GMAB
Genmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
PremiumCompany Announcements
Genmab Ends Early GEN1047 Cancer Trial, Narrowing One Pipeline Bet
1M ago
GMAB
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
PremiumThe Fly
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
1M ago
ABBV
GMAB
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
PremiumCompany Announcements
Genmab’s TIVDAK Cervical Cancer Trial Update: What a Termination Means for Investors
1M ago
GMAB
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave upgraded, IBM initiated: Wall Street’s top analyst calls
1M ago
PM
BKH
Genmab upgraded to Buy from Hold at TD Cowen
PremiumThe FlyGenmab upgraded to Buy from Hold at TD Cowen
1M ago
GMAB
Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
Premium
Company Announcements
Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market
2M ago
GMAB
Genmab reports Q2 net sales of Darzalex $4.207B
Premium
The Fly
Genmab reports Q2 net sales of Darzalex $4.207B
2M ago
JNJ
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >